MinervaX scaling up supply of novel GBS vaccine, ahead of phase III studies · Wacker Biotech to manufacture active vaccine protein ingredients and prepare for commercial supply after ...
Her history and prenatal course were uncomplicated. She had a negative group B streptococcus culture at 36 weeks. She began contracting at 7 AM and was seen for evaluation at 8 AM. At that time ...